FGH Biotech's Debt Round

FGH Biotech raised a round of funding on October 24, 2017.

FGH Biotech is committed to developing molecules for good health that control SREBP transcription factors and related pathways for the prevention and treatment of metabolic diseases.…

Articles about FGH Biotech's Debt Round: